IMMUNIS.AI
Immunis AI is the developer of a non-invasive blood-based immunogenomic platform. The startup performs detailed genomic analysis of patient blood samples to understand diseases that individuals may be harbouring and the body's immune response to those diseases. The platform's initial focus is on oncology, with plans to expand to other diseases and treatments in the future.
IMMUNIS.AI
Social Links:
Industry:
Artificial Intelligence Health Care Health Diagnostics Wellness
Founded:
2012-01-01
Address:
Royal Oak, Michigan, United States
Country:
United States
Website Url:
http://www.immunis.ai
Total Employee:
1+
Status:
Active
Contact:
+1 248 918 0468
Email Addresses:
[email protected]
Official Site Inspections
http://www.immunis.ai
- Host name: server-18-67-76-129.iad89.r.cloudfront.net
- IP address: 18.67.76.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Immunis.AI"
Immunis
Immunis.AI is a privately held company committed to making a global impact by empowering patients and their physicians with actionable information for disease management.. Our …See details»
Immunis.AI - Crunchbase Company Profile & Funding
Organization. Immunis.AI . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Immunis.AI is an immunogenomics company. …See details»
Immunis.AI Company Profile 2025: Valuation, Funding & Investors
Immunis.AI General Information Description. Developer of a non-invasive blood-based immunogenomic platform discovery platform designed to detect cancer. The company's …See details»
Immunis.AI - LinkedIn
Immunis.AI is a privately held company committed to making a global impact by empowering patients and their physicians with actionable information for disease management. Our …See details»
Immunis.AI - Products, Competitors, Financials, Employees, …
Immunis.AI is a privately held immunogenomics company committed to making a global impact by empowering patients and their physicians with actionable information for disease detection …See details»
Immunis.AI (fka OncoCell MDx) | VentureRadar
Immunis.AI is a privately held immunogenomic ‘liquid biopsy’ platform company focused on early detection of cancer and other diseases, at the point of immune-escape, when there is the best …See details»
Immunis.AI Company Profile - Office Locations, Competitors
Immunis.AI is an immunogenomics company that specializes in surveillance tests and early detection assays. Its platform enables immune defense systems, analytical methods, AI, and …See details»
Immunis.AI - Company Profile - Tracxn
Oct 31, 2024 Immunis.AI ranks 3rd among 32 active competitors. 9 of its competitors are funded Overall, Immunis.AI and its competitors have raised over $115M in funding across 16 funding …See details»
Immunis.AI Achieves Development Milestones and …
Sep 29, 2021 IMMUNIS.AI is a privately held immunogenomics company with a patented liquid biopsy platform that offers unique insights into disease biology and individualized assessment. The Intelligentia ...See details»
Immunis.AI - Funding, Financials, Valuation & Investors - Crunchbase
Sep 29, 2021 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 29, …See details»
Immunis.AI | Biotech Careers
Immunis.AI is a privately held immunogenomic ‘liquid biopsy’ platform company focused on early detection of cancer and other diseases, at the point of immune-escape, when there is the best …See details»
Immunis Company Profile 2025: Valuation, Funding & Investors
Immunis General Information Description. Developer of stem cell-derived therapy designed to treat age and disease-related immune decline. The company's technology uses human stem …See details»
Immunis.ai Company Profile | Royal Oak, MI - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Immunis.ai of Royal Oak, MI. Get the latest business insights from Dun & Bradstreet.See details»
IMMUNIS.AI Overview | SignalHire Company Profile
IMMUNIS.AI is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology area. ... Organization Website: Immunis.AI : …See details»
Immunis.AI Chosen by Amazon Web Services to Showcase its …
Oct 5, 2021 IMMUNIS.AI is a privately held immunogenomics company with a patented liquid biopsy platform that offers unique insights into disease biology and individualized assessment. …See details»
Immunis.AI | Mission Cloud
Immunis.AI plans to replicate its successful blueprint across many clinical studies throughout 2021 and beyond, as it develops and commercializes its products. Mission is continuing to support …See details»
Immunis - Crunchbase Company Profile & Funding
Organization. Immunis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Immunis a private biotechnology company …See details»
Immunis.AI - Drug pipelines, Patents, Clinical trials - Synapse
Immunis.AI therefore hypothesizes that a peripheral blood immunogenomic signature will identify patients with various stages of breast cancer from healthy negative controls. Start Date 01 Sep …See details»
Immunis.AI - Crunchbase
Companies like Immunis.AI include Context Therapeutics, HeartVista, and Pathology Asia Holdings. Context Therapeutics Philadelphia , Pennsylvania , United States 7 Contacts 1-10 …See details»
A Private Biotechnology Company in CA, USA : Immunis, Inc.
Immunis is a private biotechnology company researching and developing multi-active biologics to address age related diseases. Our investigational therapy, IMM01-STEM, leverages our …See details»